American International Team Inc. Has $19.02 Million Stake in MetLife, Inc. (Fulfilled)

American International Team Inc. reduced its stake in MetLife, Inc. (NYSE:Fulfilled) by 1.3% throughout the initially quarter, in accordance to its most current disclosure with the Securities and Exchange Fee (SEC). The organization owned 360,137 shares of the financial companies provider’s inventory following advertising 4,912 shares throughout the period. American International Team Inc.’s holdings in MetLife have been worth $19,022,000 at the finish of the most current quarter.

Other hedge resources and other institutional traders have also not long ago modified their holdings of the organization. Cigna Investments Inc. New purchased a new situation in MetLife throughout the fourth quarter worth about $2,099,000. Atria Investments LLC lifted its situation in MetLife by 2.6% in the initially quarter. Atria Investments LLC now owns 18,914 shares of the financial companies provider’s inventory worth $999,000 following acquiring an additional 488 shares in the last quarter. Prospera Financial Products and services Inc purchased a new situation in MetLife throughout the initially quarter worth about $1,525,000. Tompkins Financial Corp lifted its situation in MetLife by 40.8% in the initially quarter. Tompkins Financial Corp now owns 7,789 shares of the financial companies provider’s inventory worth $342,000 following acquiring an additional 2,258 shares in the last quarter. Eventually, UBS Asset Management Americas Inc. lifted its situation in MetLife by 3.5% in the fourth quarter. UBS Asset Management Americas Inc. now owns 4,148,498 shares of the financial companies provider’s inventory worth $223,563,000 following acquiring an additional 140,341 shares in the last quarter. Institutional traders individual 74.51% of the company’s inventory.

Shares of MetLife, Inc. (Fulfilled) traded up .13% throughout midday buying and selling on Friday, hitting $54.65. The inventory had a buying and selling quantity of 3,585,397 shares. MetLife, Inc. has a 52 7 days reduced of $38.87 and a 52 7 days high of $58.09. The stock’s sector capitalization is $58.80 billion. The inventory has a 50 day relocating common selling price of $53.79 and a 200-day relocating common selling price of $53.02.

MetLife (NYSE:Fulfilled) last posted its quarterly earnings info on Wednesday, May 3rd. The financial companies company described $1.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $.19. The organization had income of $16.27 billion throughout the quarter, in contrast to analyst estimates of $17.02 billion. MetLife had a adverse internet margin of .95% and a favourable return on fairness of 7.57%. The company’s income for the quarter was down 11.7% on a calendar year-about-calendar year foundation. Throughout the exact same quarter last calendar year, the company posted $1.20 EPS. Equities investigation analysts foresee that MetLife, Inc. will publish $5.38 earnings per share for the present calendar year.

The organization also not long ago disclosed a quarterly dividend, which will be compensated on Wednesday, September 13th. Shareholders of history on Monday, August 7th will be compensated a $.40 dividend. The ex-dividend day of this dividend is Thursday, August 3rd. This signifies a $1.60 annualized dividend and a yield of 2.93%. MetLife’s dividend payout ratio (DPR) is -258.06%.

WARNING: This report was posted by BNB Daily and is the assets of of BNB Daily. If you are viewing this report on a different internet site, it was stolen and republished in violation of worldwide copyright and trademark legislation. The appropriate edition of this report can be accessed at https://www.baseball-news-blog.com/2017/07/23/american-worldwide-group-inc-has-19-02-million-stake-in-metlife-inc-satisfied-up to date-up to date.html.

A range of investigation analysts not long ago issued experiences on Fulfilled shares. Vetr reduced MetLife from a “strong-buy” score to a “buy” score and established a $55.49 selling price goal for the organization. in a investigation report on Monday, March 27th. Wells Fargo & Business restated a “buy” score on shares of MetLife in a investigation report on Monday, March 27th. J P Morgan Chase & Co reduced their selling price focus on on MetLife from $57.00 to $54.00 and established an “overweight” score for the organization in a investigation report on Monday, April 3rd. TheStreet upgraded MetLife from a “c” score to a “b-” score in a investigation report on Monday, April 3rd. Eventually, Zacks Investment decision Exploration upgraded MetLife from a “hold” score to a “buy” score and established a $59.00 selling price focus on for the organization in a investigation report on Tuesday, April 11th. A single investigation analyst has rated the inventory with a sell score, six have assigned a maintain score, 7 have issued a get score and just one has assigned a potent get score to the organization. MetLife has a consensus score of “Buy” and an common selling price focus on of $57.03.

MetLife Business Profile

MetLife, Inc is a company of existence insurance policies, annuities, personnel benefits and asset management. The Company’s segments include things like U.S. Asia Latin America Europe, the Middle East and Africa (EMEA) MetLife Holdings Brighthouse Financial, and Corporate & Other. Its U.S. segment is structured into Team Advantages, Retirement and Revenue Solutions and Home & Casualty enterprises.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Get News & Scores for MetLife Inc. Daily – Enter your e-mail deal with below to receive a concise day by day summary of the most recent news and analysts’ scores for MetLife Inc. and similar firms with MarketBeat.com’s Free of charge day by day e-mail publication.

Leave a Reply